scispace - formally typeset
R

Richard N. Bergman

Researcher at Cedars-Sinai Medical Center

Publications -  489
Citations -  97005

Richard N. Bergman is an academic researcher from Cedars-Sinai Medical Center. The author has contributed to research in topics: Insulin & Insulin resistance. The author has an hindex of 130, co-authored 477 publications receiving 91718 citations. Previous affiliations of Richard N. Bergman include University of Southern California & University of California, Los Angeles.

Papers
More filters
Posted ContentDOI

The Trans-Ancestral Genomic Architecture of Glycaemic Traits

Ji Chen, +478 more
- 25 Jul 2020 - 
TL;DR: Genomic feature, gene-expression and gene-set analyses revealed distinct biological signatures for each trait, highlighting different underlying biological pathways, increasing understanding of diabetes pathophysiology by use of trans-ancestry studies for improved power and resolution.
Journal ArticleDOI

The Finland–United States Investigation of Non–Insulin-Dependent Diabetes Mellitus Genetics (FUSION) Study. II. An Autosomal Genome Scan for Diabetes-Related Quantitative-Trait Loci

Richard M. Watanabe, +64 more
- 01 Nov 2000 - 
TL;DR: Several regions that may harbor susceptibility genes for type 2 diabetes in the Finnish population are identified by integrating genome-scan results from the companion article by Ghosh et al.

Obesity, insulin resistance and comorbidities - Mechanisms of association Obesidade, resistência à insulina e comorbidades - Mecanismos de associação

Ana Valeria, +4 more
TL;DR: This review will highlight the current pathophysiological and molecular mechanisms possibly involved in the link between increased VAT, ectopic fat, IR and comorbidities and provide some insights in the identification of these abnormalities.
Journal ArticleDOI

Metabolic syndrome, hyperinsulinemia, and cancer

Isabel R. Hsu, +3 more
- 01 Sep 2007 - 
TL;DR: Nocturnal lipolysis secondary to sympathetic stimulation may not only cause insulin resistance but also be responsible for hyperinsulinemia by stimulating secretion and reducing clearance of insulin by the liver, which may synergize and increase the risk of some cancers.
Journal ArticleDOI

Pioglitazone Increases Insulin Sensitivity, Reduces Blood Glucose, Insulin, and Lipid Levels, and Lowers Blood Pressure, in Obese, Insulin-Resistant Rhesus Monkeys

Joseph W. Kemnitz, +5 more
- 01 Feb 1994 - 
TL;DR: Pioglitazone hydrochloride significantly improved fasting and postprandial levels of IRI, plasma glucose, and TG in a dose-related manner and was more marked for those animals with fasting hyperglycemia.